Ora Names Gustavo De Moraes, MD, PHD, Chief Medical Officer
Ora announced that distinguished ophthalmologist and researcher, Gustavo De Moraes, MD, PhD, MPH, has accepted the role of Chief Medical Officer (CMO).
Dr. De Moraes will lead Ora’s clinical trial design team of ophthalmic disease experts, statisticians, pharmacologists, and regulatory affairs personnel, as well as guide the development of novel models, endpoints, and technology with Ora R&D. Additionally, he will oversee education, trial safety, and adverse event monitoring for Ora’s global clinical operations and engage with sponsors to assure proper disease subgroup selection in relation to regulatory-validated endpoints.
“Ora's technology, operational excellence, and talented team have been critical to building our reputation for accelerating research and development programs to bring improved therapies to patients,” Ora’s President, Chairman and CEO, Stuart B. Abelson. "Dr. De Moraes’ unique skills, knowledge and collaborative data-driven approach will enhance our ability to deliver exceptional value to our clients across every phase of development.”
“Ora has assembled a team of experts dedicated to advising and problem solving within a high-performance operating model that has consistently demonstrated excellence in both decision-making and execution,” said Dr. De Moraes. “It’s a service/delivery model that extends far beyond the traditional offering. Ora’s level of specialization and commitment to ophthalmic innovation is unmatched. I’m honored to be joining their leadership community and passionate about what we can accomplish together.”
Recognized as one of the top glaucoma experts, Dr. De Moraes has received prestigious honors throughout his academic and professional careers. After earning his medical degree, he solidified his position as a global leader in ophthalmic neuroprotective disorders with fellowships in both retina and glaucoma. In addition to holding a PhD in ophthalmic sciences and a master’s degree in public health with a focus on biostatistics, he also serves as Associate Professor of Ophthalmology at Columbia University and as an attending physician at New York Presbyterian. Previously, Dr. De Moraes headed the Glaucoma Research Department at New York Eye & Ear Infirmary of Mount Sinai and conducted research at New York University Medical Center.